byiShook Opinion
Aug 8, 2024 - 09:00
Eli Lilly earnings easily beat amid booming sales of weight-loss drug Zepbound and diabetes fighter Mounjaro. The drug giant raised guidance. Eli Lilly stock jumped. The post Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound, Mounjaro Sales Boom appeared first on Investor's Business Daily.
Eli Lilly earnings easily beat amid booming sales of weight-loss drug Zepbound and diabetes fighter Mounjaro. The drug giant raised guidance. Eli Lilly stock jumped.
The post Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound, Mounjaro Sales Boom appeared first on Investor's Business Daily.